- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0120386

Glenohill Pharmaceutical Private Limited
About Glenohill Pharmaceutical Private Limited
Data last updated:
Glenohill Pharmaceutical Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2018PTC317153.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Priyanka Tiwari and Kedar Nath Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No. 18 New Rathod Layout Anant Nagar Road Gorewada, Nagpur, Maharashtra, India – 440013.
As per the financials filed for FY 2024, the company reported a revenue of ₹63.54 Lakh, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹10,638 (net margin 0.2%) and EBITDA of ₹1.53 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years.
Glenohill Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0120386).
Company details
Recognitions & Rankings of Glenohill Pharmaceutical
Contact details
Glenohill Pharmaceutical Private Limited's registered office is in Nagpur, Maharashtra.
- Registered AddressP.No. 18 New Rathod Layout Anant Nagar Road Gorewada, Nagpur, Maharashtra, India – 440013
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Glenohill Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Glenohill Pharmaceutical Private Limited, buy the company report.
Financials of Glenohill Pharmaceutical Private Limited
FY 2025 filings availableGlenohill Pharmaceutical Private Limited reported revenue of ₹63.54 Lakh (up 22% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over three years, including 22% growth in the latest year. EBITDA rose 317% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10,638 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glenohill Pharmaceutical Private Limited, buy the company report.
Board of directors of Glenohill Pharmaceutical Private Limited
Glenohill Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Tiwari | Director | 16 Nov 2018 | 7 Years 11 Months | Current |
| Kedar Nath Mishra | Director | 15 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Glenohill Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sandarv Trading Private Limited | ₹63.55 Lakh (FY 2025) | -90.0% | Kolkta, West Bengal, India | |||
| Bhose Jyotirling Farmer Producer Company Limited | ₹63.54 Lakh (FY 2024) | 677.0% | Satara, Maharashtra, India | |||
| Nuvesh Innovations Private Limited | ₹63.54 Lakh (FY 2025) | 23.0% | Karnal, Haryana, India | |||
| GRT Ageless Private Limited | ₹63.54 Lakh (FY 2025) | -77.0% | Bokaro, Jharkhand, India | |||
| Santosh Herbal Extracts Private Limited | ₹63.54 Lakh (FY 2017) | -6.0% | Raipur, Chhattisgarh, India | |||
| Glenohill Pharmaceutical Private Limitedthis company | ₹63.54 Lakh (FY 2024) | ₹10,638 | 0.2% | 22.0% | Nagpur, Maharashtra, India | |
| Robotic Aviation Private Limited | ₹63.52 Lakh (FY 2024) | 129.0% | Delhi, India | |||
| Indocross Laboratories Private Limited | ₹63.52 Lakh (FY 2024) | -35.0% | Haridwar, Uttarakhand, India | |||
| Aroha Tradelink Private Limited | ₹63.52 Lakh (FY 2025) | -17.0% | Kolkata, West Bengal, India | |||
| Iheal Healthtech Private Limited | ₹63.52 Lakh (FY 2024) | 65.0% | Shimla, Himachal Pradesh, India | |||
| Ezeelo Consumer Services Private Limited | ₹63.52 Lakh (FY 2021) | 32.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Glenohill Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Glenohill Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glenohill Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Glenohill Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Glenohill Pharmaceutical Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Arun Kumar Dubey ceased to be Director on 20 Apr 2019.
Frequently asked questions
Glenohill Pharmaceutical is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 November 2018 (8+ years old) and is registered under CIN U85100MH2018PTC317153.
Glenohill Pharmaceutical has 2 current directors:
- Priyanka Tiwari - Director
- Kedar Nath Mishra - Director
The latest financial statements of Glenohill Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Glenohill Pharmaceutical is U85100MH2018PTC317153. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glenohill Pharmaceutical was incorporated on 16 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Glenohill Pharmaceutical by revenue are Sandarv Trading Private Limited, Bhose Jyotirling Farmer Producer Company Limited, Nuvesh Innovations Private Limited, GRT Ageless Private Limited, Santosh Herbal Extracts Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Arun Kumar Dubey ceased to be Director on 20 Apr 2019. Kedar Nath Mishra was appointed as Director on 15 Dec 2018. Priyanka Tiwari was appointed as Director on 16 Nov 2018.
Yes, Glenohill Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0120386).
The registered office of Glenohill Pharmaceutical is at P.No. 18 New Rathod Layout Anant Nagar Road Gorewada, Nagpur, Maharashtra, India – 440013.
Glenohill Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Glenohill Pharmaceutical can be reached at its registered office: P.No. 18 New Rathod Layout Anant Nagar Road Gorewada, Nagpur, Maharashtra, India – 440013.

